AA
RCKT icon

ALPS Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

ALPS Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-52,273
Closed -$895K – 1025
2023
Q1 		$895K Sell
52,273
-1,096
-2% -$21.5K 0.01% 493
2022
Q4 		$1.04M Buy
53,369
+17,339
+48% +$319K 0.01% 472
2022
Q3 		$575K Sell
36,030
-3,024
-8% -$47.2K 0.01% 570
2022
Q2 		$537K Sell
39,054
-27,240
-41% -$325K 0.01% 569
2022
Q1 		$1.05M Sell
66,294
-8,283
-11% -$143K 0.01% 307
2021
Q4 		$1.63M Sell
74,577
-3,393
-4% -$92.6K 0.02% 306
2021
Q3 		$2.33M Sell
77,970
-5,133
-6% -$187K 0.02% 267
2021
Q2 		$3.68M Sell
83,103
-28,669
-26% -$1.25M 0.03% 197
2021
Q1 		$4.96M Buy
111,772
+12,019
+12% +$660K 0.05% 176
2020
Q4 		$5.47M Buy
99,753
+29,372
+42% +$1.07M 0.06% 170
2020
Q3 		$1.61M Sell
70,381
-4,865
-6% -$120K 0.02% 261
2020
Q2 		$1.57M Sell
75,246
-23,245
-24% -$419K 0.02% 259
2020
Q1 		$1.37M Sell
98,491
-2,975
-3% -$58.9K 0.02% 240
2019
Q4 		$2.31M Buy
+101,466
New +$1.69M 0.02% 216
2018
Q4 		– Sell
-70,185
Closed -$1.73M – 927
2018
Q3 		$1.73M Buy
70,185
+13,008
+23% +$282K 0.01% 272
2018
Q2 		$1.12M Buy
+57,177
New +$1.08M 0.01% 314
2017
Q2 		– Sell
-5,792
Closed -$46K – 783
2017
Q1 		$46K Sell
5,792
-678
-10% -$4.56K ﹤0.01% 727
2016
Q4 		$158K Sell
6,470
-2,113
-25% -$60.3K ﹤0.01% 702
2016
Q3 		$325K Sell
8,583
-697
-8% -$21.9K ﹤0.01% 640
2016
Q2 		$276K Buy
9,280
+1,855
+25% +$65.2K ﹤0.01% 586
2016
Q1 		$220K Sell
7,425
-1,273
-15% -$38.2K ﹤0.01% 600
2015
Q4 		$394K Buy
+8,698
New +$379K ﹤0.01% 603

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

ALPS Advisors's RCKT Position: Q2 2023 in Review

ALPS Advisors sold out of Rocket Pharmaceuticals (RCKT) in Q2 2023, closing a stake of 52,273 shares — an estimated $895K sold.

ALPS Advisors first reported a position in RCKT in Q4 2015 and held it in 22 quarters. The position peaked at $5.47M in Q4 2020. 164 funds tracked by Wall St. Rank hold RCKT as of Q2 2023.

  • ALPS Advisors reported no remaining Rocket Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • ALPS Advisors sold 52,273 Rocket Pharmaceuticals shares in Q2 2023, an estimated $895K.
  • ALPS Advisors first reported a position in Rocket Pharmaceuticals in Q4 2015 and held it in 22 quarters.
  • ALPS Advisors's Rocket Pharmaceuticals position peaked at $5.47M in Q4 2020.
  • 164 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2023.

Based on ALPS Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.